PlainRecalls
FDA Drug Low Class III Terminated

Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01

Reported: January 12, 2022 Initiated: December 29, 2021 #D-0358-2022

Product Description

Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01

Reason for Recall

Out-of-specification impurity test result observed at 18-month long term stability time point.

Details

Units Affected
23,965 100 count bottles
Distribution
Product Distributed in NY and OH.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 23,965 100 count bottles.
Why was this product recalled?
Out-of-specification impurity test result observed at 18-month long term stability time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 12, 2022. Severity: Low. Recall number: D-0358-2022.